期刊文献+

抗精神病药对精神分裂症患者体重的影响 被引量:8

The effects of antipsychotic drug on schizophrenic patients weight gain.
下载PDF
导出
摘要 目的 为了探讨抗精神病药对精神分裂症患者体重的影响。方法 对 2 95例服用抗精神病药的精神分裂症患者进行了临床调查。结果  6 7 12 %患者出现体重增加 ;体重增加从多到少的药物依次是氯氮平、奥氮平、氯氮平合并利培酮、氯丙嗪、利培酮、氯氮平合并舒必利 ;氯氮平、氯丙嗪、利培酮体重增加较入组前有显著差异 ;女性患者、初次服抗精神病药者、合并心境稳定剂者体重增加亦明显。结论 大部分抗精神病药可导致体重增加 。 Objective To explore the effects of antipsychotic drugs on weight gain.Method 295 schizophrenic patients treated with antipsychotic drugs were studied clinically.Results 67.12% schizophrenic patients weight have been increased,the drugs affect weight gain from many to few:clozapine,olanzapine,combined clozapine with risperidone largactil,risperidone,combined clozapine with sulperide.The increased weight after clozapine treated showed obvious difference,and risperidone targactil also.In women patients,first take medicine and united with mood stabilzers could increased weight obviously.Conclusion Many antipsychotic drugs could increase the weight.We should check weight regularly in and before the treatment.
作者 刘红霞 刘霞
出处 《四川精神卫生》 2003年第4期199-200,共2页 Sichuan Mental Health
关键词 抗精神病药 精神分裂症 体重 Antipsychotic drugs Schizophrenia Weight
  • 相关文献

参考文献3

二级参考文献25

  • 1[2]Halmi Ka. Leptin: the designer hormone of 90s. Molecular Psychiatry, 1998, 3 : 477
  • 2[3]Mantzoras C. Leptin and hypothamus: neuroendocine regulation of food intake. Molecular Psychiatry, 1998, 4 : 8
  • 3[5]Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Natrue, 1994, 372 :425
  • 4[6]Ma ZM. Radiommunoassay of leptin in human plasma. Clin Chem,1996, 42 : 942
  • 5[7]McIntyre RS, Mancini DA, Basile VS. Mechanisms of antipsychotic-induced weight gain. JClin Psychiatry, 2001, 62 Suppl 23: 23
  • 6[8]Johann Wolfgang Bodyweight gain with atypical antipsychotics. A comparative review. Drug Saf, 2001 Jan, 24(1) : 59
  • 7[9]Bromel T, Blum WF, Ziegler A, et al. Serum leptin levels increase rapidly after initiationof clozapine therapy. Molecular psychiatry,1998, 3 : 76
  • 8[10]Moller N, O'brien P, Nair KS, et al. Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Endocrinol Metab, 1998, 83 : 931
  • 9[11]Weigle Ds, Ganter SL, Kuijper JL, et al. Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J Clin Endocrionl Metab, 1997, 82 : 566
  • 10[12]Caro JF, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity a possible mechanism for leptin resitance. Lancet, 1996,348: 159

共引文献51

同被引文献94

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部